Guided Therapeutics (OTCMKTS:GTHP) Trading 38.9% Higher – What’s Next?

Shares of Guided Therapeutics, Inc. (OTCMKTS:GTHP) rose 38.9% during mid-day trading on Friday . The company traded as high as $0.14 and last traded at $0.13. Approximately 14,476 shares changed hands during mid-day trading, a decline of 10% from the average daily volume of 16,063 shares. The stock had previously closed at $0.09.

Guided Therapeutics Price Performance

The stock has a fifty day moving average price of $0.10 and a two-hundred day moving average price of $0.13. The company has a market cap of $9.86 million, a P/E ratio of -4.17 and a beta of 0.21.

Guided Therapeutics (OTCMKTS:GTHP) last issued its quarterly earnings results on Thursday, May 15th. The company reported ($0.01) EPS for the quarter.

Guided Therapeutics Company Profile

Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.